NCT06309303View on ClinicalTrials.gov

Kawasaki Disease During the COVID-19 Epidemic

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Kawasaki Disease
Interventions
OTHER

Clinical evaluation

Evaluation of clinical manifestation, laboratory ad imaging testing results, disease course, treatment and outcome

Trial Locations (4)

34137

IRCCS Burlo Garofolo, Trieste

Unknown

Ospedale Pediatrico Meyer, Florence

IRCCS Istituto Giannina Gaslini, Genova

Ospedale Pediatrico Bambino Gesù, Roma

All Listed Sponsors
lead

IRCCS Burlo Garofolo

OTHER

NCT06309303 - Kawasaki Disease During the COVID-19 Epidemic | Biotech Hunter | Biotech Hunter